Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of the American Heart Association|August 14, 2020
Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy ModelTakaaki Samura, Shigeru Miyagawa, Takuji Kawamura, et al.Journal of the American Heart Association|July 2, 2021
Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated CardiomyopathyKeitaro Domae, Shigeru Miyagawa, Yasushi Yoshikawa, et al.Frontiers in Cardiovascular Medicine|September 2, 2022
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathyShigeru Miyagawa, Satoshi Kainuma, Takuji Kawamura, et al.Frontiers in Cardiovascular Medicine|October 2, 2023
Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reportsTakuji Kawamura, Yoshito Ito, Emiko Ito, et al.Human Molecular Genetics|May 5, 2021
Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytesMikio Shiba, Shuichiro Higo, Takumi Kondo, et al.Stem Cell Research & Therapy|March 13, 2024
Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patchShigeru Miyagawa, Takuji Kawamura, Emiko Ito, et al.Iscience|February 9, 2024
Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessmentJunjun Li, Ying Hua, Yuting Liu, et al.Stem Cell Reports|January 22, 2022
Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytesHiroyuki Inoue, Satoki Nakamura, Shuichiro Higo, et al.Circulation. Genomic and Precision Medicine|July 21, 2022
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for <i>TNNT2</i> Δ160E-Induced CardiomyopathyTakumi Kondo, Shuichiro Higo, Mikio Shiba, et al.Pageof 3